PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces it has submitted a ...

Ke, X. and Ma, T. (2025) Protective Effect of Liraglutide on Early Renal Fibrosis in Diabetes Mice. Journal of Biosciences and Medicines, 13, 84-91. doi: 10.4236/jbm.2025.131008 .

Senior Department of Ophthalmology, The Third Medical Center of PLA General Hospital, PLA General Hospital and PLA Medical College, Beijing, China The high risks of traumatic cataract treatments ...

Korean researchers have developed a technology that treats colon cancer by converting cancer cells into a state resembling normal colon cells. Listen to Story Researchers in South Korea have developed ...

Scientists found that healthy women can carry genetic changes in their breast cells that are thought to be characteristic of invasive breast cancer.

Here, we employ tissue-scale stress and compressibility measurements and theoretical modeling to unveil a mechanical imbalance between normal and transformed cells, which drives cell competition. In ...

However, the gut microbiome and immune-related microfold cells in the intestinal epithelium might also contribute to the observed effects in normal mice. Moreover, the loss of villi and stem cells ...

The KAIST team took a radically different approach by targeting the root causes of cancer development. They created a digital twin of the gene network involved in the differentiation trajectory of ...

Cancer cells divide more rapidly than normal cells, so most cancer treatments focus on killing these fast-dividing cells. However, this often leads to side effects since normal cells can also be ...